About Alexandra Santu

This author has not yet filled in any details.
So far Alexandra Santu has created 26 blog entries.
<br>Understanding cross-resistance: A microbiological and epidemiological perspective</br><em> – by Ana Cristina Gales</em>
24 July 2025

Understanding cross-resistance: A microbiological and epidemiological perspective – by Ana Cristina Gales

more
<br>Crippling Gram-negative bacterial efflux of antibiotics </br><em> – by Marion Flipo and Ruben C. Hartkoorn </em>
13 May 2025

Crippling Gram-negative bacterial efflux of antibiotics – by Marion Flipo and Ruben C. Hartkoorn

more
<br>Who will protect the sheep from the wolves? – The increasing urgent need for antimicrobial stewardship worldwide</br><em> – by Debra A. Goff </em>
20 March 2024

Who will protect the sheep from the wolves? – The increasing urgent need for antimicrobial stewardship worldwide – by Debra A. Goff ...

more
<br>Bioinspired peptides as an alternative strategy for controlling multidrug-resistant bacteria </br><em> – by Octávio Luiz Franco </em>
19 February 2024

Bioinspired peptides as an alternative strategy for controlling multidrug-resistant bacteria – by Octávio Luiz Franco

more
<br>The value of diagnostics in the fight against antimicrobial resistance</br><em> – by Rosanna W. Peeling, David L. Heymann & Debi Boeras </em>
25 January 2024

The value of diagnostics in the fight against antimicrobial resistance – by Rosanna W. Peeling, David L. Heymann & Debi Boeras

more
<br>Sulbactam plus durlobactam: a new addition to antibacterial therapies </br><em> – by Ursula Theuretzbacher </em>
20 December 2023

Sulbactam plus durlobactam: a new addition to antibacterial therapies – by Ursula Theuretzbacher

more
<br>The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly approved antibiotics</br><em> – by Benedikt Huttner, Lorenzo Moja & Mike Sharland </em>
13 December 2023

The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly ...

more
<br>Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs</br><em> – by Christoph M. Tang, Ann Jerse, Martin C. J. Maiden and William M. Shafer </em>
6 December 2023

Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs – by Christoph M. Tang, ...

more
<br>Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development </br><em> – by Tina Guina and Edward A. Weinstein </em>
29 November 2023

Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development – by Tina Guina and Edward A. Weinstein ...

more
<br>Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope</br><em> – by Jacob Madden, Timo Minssen & Aaron S. Kesselheim </em>
27 September 2023

Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope – by Jacob Madden, Timo ...

more
© All Rights Reserved
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top